Published mark
AbbVie
AbbVie Inc.
NYSE: ABBV. AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:90c6a136-4c2d-4811-8406-243e5de58c6a
- SEC CIK
- 0001551152
- Website
- www.abbvie.com Open
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 16, 2026
- Newest evidence
- May 3, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Robert A. MichaelSince Feb 20, 2026
- Chair
- Robert A. MichaelLead independent: Roxanne S. Austin
- Independent
- Not published12 directors published
- Published claims
- 575 distinct sources
- Evidence records
- 280 pinned
- Source conflicts
- 0None open
Built from 5 distinct sources and 28 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
EXECUTIVE APPOINTED
Azita Saleki-Gerhardt executive of AbbVie, effective 2026-02-20.
EffectiveEffective Feb 20, 2026E15
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Executive Vice President, Chief Operations Officer | Azita Saleki-Gerhardt | Feb 2026 | current | Source reportedE15 |
| Senior Vice President, Controller | David R. Purdue | Feb 2026 | current | Source reportedE17 |
| Executive Vice President, Chief Human Resources Officer | Demetris D. Crum | Feb 2026 | current | Source reportedE18 |
| Executive Vice President, Chief Business and Strategy Officer | Nicholas J. Donoghoe | Feb 2026 | current | Source reportedE20 |
| Executive Vice President, General Counsel and Secretary | Perry C. Siatis | Feb 2026 | current | Source reportedE22 |
| Chairman of the Board and Chief Executive Officer | Robert A. Michael | Feb 2026 | current | Source reportedE23 |
| Executive Vice President, Research Development and Chief Scientific Officer | Roopal Thakkar | Feb 2026 | current | Source reportedE24 |
| Executive Vice President, Chief Financial Officer | Scott T. Reents | Feb 2026 | current | Source reportedE26 |
| Executive Vice President, Chief Operations Officer | Azita Saleki-Gerhardt, Ph.D. | Not captured | unknown | Source reportedE16 |
| Executive Vice President, Chief Commercial Officer | Jeffrey R. Stewart | Not captured | unknown | Source reportedE19 |
| Executive Vice President, Chief Business and Strategy Officer | Nicholas J. Donoghoe, M.D. | Not captured | unknown | Source reportedE21 |
| Executive Vice President, Research Development and Chief Scientific Officer | Roopal Thakkar, M.D. | Not captured | unknown | Source reportedE25 |
Board of directors
Evidence12 directors published. Independence determinations are not published for every director.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Brandon L. Hart | Independence not published | 2016 | Compensation, chairCompensation · Chair; Nominations & GovernanceNominations & Governance | Source reportedE4 |
| Edward J. Rapp | Independence not published | 2013 | AuditAudit; Nominations & GovernanceNominations & Governance | Source reportedE5 |
| Frederick H. Waddell | Independence not published | 2013 | Audit, chairAudit · Chair; CompensationCompensation | Source reportedE6 |
| Jennifer L. Davis | Independence not published | 2023 | Nominations & Governance | Source reportedE7 |
| Marcia K. Meyer | Independence not published | 2017 | AuditAudit; Public Policy & Sustainability · ChairPublic Policy & Sustainability, chair | Source reportedE8 |
| Rebecca B. Roberts | Independence not published | 2018 | Nominations & GovernanceNominations & Governance; Public Policy & SustainabilityPublic Policy & Sustainability | Source reportedE9 |
| Robert A. Michael | Independence not publishedChair | 2024 | None published | Source reportedE3 |
| Roxanne S. Austin | Independence not publishedLead Independent | 2013 | AuditAudit; Compensation; Nominations & Governance; Public Policy & SustainabilityCompensationNominations & GovernancePublic Policy & Sustainability | Source reportedE10 |
| Susan E. Quaggin | Independence not published | 2023 | Public Policy & Sustainability | Source reportedE11 |
| Thomas C. Freyman | Independence not published | 2020 | CompensationCompensation; Nominations & Governance · ChairNominations & Governance, chair | Source reportedE12 |
| Thomas J. Falk | Independence not published | 2025 | Audit | Source reportedE13 |
| William H.L. Burnside | Independence not published | 2013 | None published | Source reportedE14 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Frederick H. Waddell | Frederick H. Waddell, Edward J. Rapp, Marcia K. Meyer, Roxanne S. Austin, Thomas J. Falk | Not described in the published record |
| Audit · Chair; Compensation | Not published | Frederick H. Waddell | Not described in the published record |
| Audit; Compensation; Nominations & Governance; Public Policy & Sustainability | Not published | Roxanne S. Austin | Not described in the published record |
| Audit; Nominations & Governance | Not published | Edward J. Rapp | Not described in the published record |
| Audit; Public Policy & Sustainability · Chair | Not published | Marcia K. Meyer | Not described in the published record |
| Compensation | Brandon L. Hart | Brandon L. Hart, Frederick H. Waddell, Roxanne S. Austin, Thomas C. Freyman | Not described in the published record |
| Compensation · Chair; Nominations & Governance | Not published | Brandon L. Hart | Not described in the published record |
| Compensation; Nominations & Governance · Chair | Not published | Thomas C. Freyman | Not described in the published record |
| Nominations & Governance | Thomas C. Freyman | Thomas C. Freyman, Brandon L. Hart, Edward J. Rapp, Jennifer L. Davis, Rebecca B. Roberts, Roxanne S. Austin | Not described in the published record |
| Nominations & Governance; Public Policy & Sustainability | Not published | Rebecca B. Roberts | Not described in the published record |
| Public Policy & Sustainability | Marcia K. Meyer | Marcia K. Meyer, Rebecca B. Roberts, Roxanne S. Austin, Susan E. Quaggin | Not described in the published record |
Committee RecordAudit: Chair Frederick H. Waddell; Members Frederick H. Waddell (Chair); Edward J. Rapp; Marcia K. Meyer; Roxanne S. Austin; Thomas J. Falk
Committee AppointmentFrederick H. Waddell: chair, Audit
Committee AppointmentEdward J. Rapp: member, Audit
Committee AppointmentMarcia K. Meyer: member, Audit
Committee AppointmentRoxanne S. Austin: member, Audit
Committee AppointmentThomas J. Falk: member, Audit
Committee RecordCompensation: Chair Brandon L. Hart; Members Brandon L. Hart (Chair); Frederick H. Waddell; Roxanne S. Austin; Thomas C. Freyman
Committee AppointmentBrandon L. Hart: chair, Compensation
Committee AppointmentFrederick H. Waddell: member, Compensation
Committee AppointmentRoxanne S. Austin: member, Compensation
Committee AppointmentThomas C. Freyman: member, Compensation
Committee RecordNominations & Governance: Chair Thomas C. Freyman; Members Thomas C. Freyman (Chair); Brandon L. Hart; Edward J. Rapp; Jennifer L. Davis; Rebecca B. Roberts; Roxanne S. Austin
Committee AppointmentThomas C. Freyman: chair, Nominations & Governance
Committee AppointmentBrandon L. Hart: member, Nominations & Governance
Committee AppointmentEdward J. Rapp: member, Nominations & Governance
Committee AppointmentJennifer L. Davis: member, Nominations & Governance
Committee AppointmentRebecca B. Roberts: member, Nominations & Governance
Committee AppointmentRoxanne S. Austin: member, Nominations & Governance
Committee RecordPublic Policy & Sustainability: Chair Marcia K. Meyer; Members Marcia K. Meyer (Chair); Rebecca B. Roberts; Roxanne S. Austin; Susan E. Quaggin
Committee AppointmentMarcia K. Meyer: chair, Public Policy & Sustainability
Committee AppointmentRebecca B. Roberts: member, Public Policy & Sustainability
Committee AppointmentRoxanne S. Austin: member, Public Policy & Sustainability
Committee AppointmentSusan E. Quaggin: member, Public Policy & Sustainability
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Principal executive officerRobert A. Michael, Chairman of the Board and Chief Executive Officer, from Feb 20, 2026
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceIndex MembershipS&P 500 (SPX)
Security ListingABBV (NYSE)
Index memberships1 membership attached to a specific security and listing.Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.
SPX
Source reportedAs of Oct 16, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
| Index | Security | Status | Effective | Verification | Source |
|---|---|---|---|---|---|
| S&P 500 (S&P Dow Jones Indices) | NYSE: ABBV | current | Dec 31, 2012 | inferred | Slickcharts S&P 500 constituent table (public observation, not S&P DJI license) |
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NameAbbVie Inc.
Entity StatusPublic listing published
Official Websitehttps://www.abbvie.com
Published FactUS
Published FactDE
Published FactHealthcare
Published FactDrug Manufacturers
Published Facthttps://www.abbvie.com
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Azita Saleki-GerhardtExecutive Vice President, Chief Operations Officercompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:22
- David R. PurdueSenior Vice President, Controllercompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:24
- Demetris D. CrumExecutive Vice President, Chief Human Resources Officercompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:25
- Nicholas J. DonoghoeExecutive Vice President, Chief Business and Strategy Officercompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:27
- Perry C. SiatisExecutive Vice President, General Counsel and Secretarycompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:29
- Robert A. MichaelChairman of the Board and Chief Executive Officercompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:30, company:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:10
- Roopal ThakkarExecutive Vice President, Research Development and Chief Scientific Officercompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:31
- Scott T. ReentsExecutive Vice President, Chief Financial Officercompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:33
- Azita Saleki-Gerhardt, Ph.D.Executive Vice President, Chief Operations Officercompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:23
- Jeffrey R. StewartExecutive Vice President, Chief Commercial Officercompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:26
- Nicholas J. Donoghoe, M.D.Executive Vice President, Chief Business and Strategy Officercompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:28
- Roopal Thakkar, M.D.Executive Vice President, Research Development and Chief Scientific Officercompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:32
- Brandon L. HartDirectorcompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:11
- Edward J. RappDirectorcompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:12
- Frederick H. WaddellDirectorcompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:13
- Jennifer L. DavisDirectorcompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:14
- Marcia K. MeyerDirectorcompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:15
- Rebecca B. RobertsDirectorcompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:16
- Roxanne S. AustinLead Independent Directorcompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:17
- Susan E. QuagginDirectorcompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:18
- Thomas C. FreymanDirectorcompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:19
- Thomas J. FalkDirectorcompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:20
- William H.L. BurnsideDirectorcompany:90c6a136-4c2d-4811-8406-243e5de58c6a:leadership_role:21
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 28 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 16, 2026. Cited by 7 Claims.
- E2AbbVie Inc. Form 10-K (filed 2026-02-20). SEC filing. Retrieved Aug 29, 2026. Cited by 2 Claims.
- E3sec filing. Published Mar 23, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E4sec filing. Published Mar 23, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E5sec filing. Published Mar 23, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E6sec filing. Published Mar 23, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E7sec filing. Published Mar 23, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E8sec filing. Published Mar 23, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E9sec filing. Published Mar 23, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E10sec filing. Published Mar 23, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E11sec filing. Published Mar 23, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E12sec filing. Published Mar 23, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E13sec filing. Published Mar 23, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E14sec filing. Published Mar 23, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E15sec filing. Published Feb 20, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E16ABBV executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E17sec filing. Published Feb 20, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E18sec filing. Published Feb 20, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E19ABBV executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E20sec filing. Published Feb 20, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E21ABBV executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E22sec filing. Published Feb 20, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E23sec filing. Published Feb 20, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E24sec filing. Published Feb 20, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E25ABBV executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E26sec filing. Published Feb 20, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E27board_seats. sp500-board-director-completeness-remediation-2026-05-15. Cited by 23 Claims.
- E28Slickcharts S&P 500 constituent table (public observation, not S&P DJI license). index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 16, 2026- Azita Saleki-Gerhardt executive of AbbVie, effective 2026-02-20.
- David R. Purdue executive of AbbVie, effective 2026-02-20.
- Demetris D. Crum executive of AbbVie, effective 2026-02-20.
- Nicholas J. Donoghoe executive of AbbVie, effective 2026-02-20.
- Perry C. Siatis executive of AbbVie, effective 2026-02-20.
- Robert A. Michael executive of AbbVie, effective 2026-02-20.
- Roopal Thakkar executive of AbbVie, effective 2026-02-20.
- Scott T. Reents executive of AbbVie, effective 2026-02-20.
- Thomas J. Falk seat on AbbVie, effective 2025-01-01.
- Robert A. Michael seat on AbbVie, effective 2024-01-01.
- Robert A. Michael chairs board AbbVie, effective 2024-01-01.
- Jennifer L. Davis seat on AbbVie, effective 2023-01-01.
- Susan E. Quaggin seat on AbbVie, effective 2023-01-01.
- Thomas C. Freyman seat on AbbVie, effective 2020-01-01.
- Compensation; Nominations & Governance · Chair committee of AbbVie, effective 2020-01-01.
- Thomas C. Freyman member of Compensation; Nominations & Governance · Chair, effective 2020-01-01.
- Rebecca B. Roberts seat on AbbVie, effective 2018-01-01.
- Nominations & Governance; Public Policy & Sustainability committee of AbbVie, effective 2018-01-01.
- Rebecca B. Roberts member of Nominations & Governance; Public Policy & Sustainability, effective 2018-01-01.
- Marcia K. Meyer seat on AbbVie, effective 2017-01-01.
- Audit; Public Policy & Sustainability · Chair committee of AbbVie, effective 2017-01-01.
- Marcia K. Meyer member of Audit; Public Policy & Sustainability · Chair, effective 2017-01-01.
- Brandon L. Hart seat on AbbVie, effective 2016-01-01.
- Compensation · Chair; Nominations & Governance committee of AbbVie, effective 2016-01-01.
- Brandon L. Hart member of Compensation · Chair; Nominations & Governance, effective 2016-01-01.
- Edward J. Rapp seat on AbbVie, effective 2013-01-01.
- Frederick H. Waddell seat on AbbVie, effective 2013-01-01.
- Roxanne S. Austin seat on AbbVie, effective 2013-01-01.
- Roxanne S. Austin lead independent director of AbbVie, effective 2013-01-01.
- William H.L. Burnside seat on AbbVie, effective 2013-01-01.
- Audit · Chair; Compensation committee of AbbVie, effective 2013-01-01.
- Frederick H. Waddell member of Audit · Chair; Compensation, effective 2013-01-01.
- Audit; Compensation; Nominations & Governance; Public Policy & Sustainability committee of AbbVie, effective 2013-01-01.
- Roxanne S. Austin member of Audit; Compensation; Nominations & Governance; Public Policy & Sustainability, effective 2013-01-01.
- Audit; Nominations & Governance committee of AbbVie, effective 2013-01-01.
- Edward J. Rapp member of Audit; Nominations & Governance, effective 2013-01-01.